These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29075359)

  • 1. Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.
    Guo Y; Peng Y; Gao D; Zhang M; Yang W; Linghu E; Herman JG; Fuks F; Dong G; Guo M
    Clin Epigenetics; 2017; 9():116. PubMed ID: 29075359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of TMEM176A activates ERK signaling in human hepatocellular carcinoma.
    Li H; Zhang M; Linghu E; Zhou F; Herman JG; Hu L; Guo M
    Clin Epigenetics; 2018 Nov; 10(1):137. PubMed ID: 30400968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.
    Yuan YH; Wang HY; Lai Y; Zhong W; Liang WL; Yan FD; Yu Z; Chen JK; Lin Y
    Cell Commun Signal; 2019 Jan; 17(1):9. PubMed ID: 30683109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
    Li X; Yu J; Brock MV; Tao Q; Herman JG; Liang P; Guo M
    Oncotarget; 2015 May; 6(13):11547-60. PubMed ID: 25909168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-224 promotion of cell migration and invasion by targeting Homeobox D 10 gene in human hepatocellular carcinoma.
    Li Q; Ding C; Chen C; Zhang Z; Xiao H; Xie F; Lei L; Chen Y; Mao B; Jiang M; Li J; Wang D; Wang G
    J Gastroenterol Hepatol; 2014 Apr; 29(4):835-42. PubMed ID: 24219032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.
    Shen B; Jiang Y; Chen YR; Zheng HC; Zeng W; Li YY; Yin A; Nie Y
    Oncol Rep; 2016 Jul; 36(1):494-502. PubMed ID: 27222429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
    Zhao R; Wang N; Huang H; Ma W; Yan Q
    Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
    Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X
    Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis.
    Wang L; Chen S; Xue M; Zhong J; Wang X; Gan L; Lam EK; Liu X; Zhang J; Zhou T; Yu J; Jin H; Si J
    Mol Med; 2012 May; 18(1):389-400. PubMed ID: 22160393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
    Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-520f inhibits hepatocellular carcinoma cell proliferation and invasion by targeting TM4SF1.
    Du X; Fan W; Chen Y
    Gene; 2018 May; 657():30-38. PubMed ID: 29505836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
    He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L
    Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma.
    Li Z; Zhang H; Yang J; Hao T; Li S
    Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Wang J; Dong L; Xu L; Chu ES; Chen Y; Shen J; Li X; Wong CC; Sung JJ; Yu J
    Cancer Lett; 2014 Dec; 355(2):192-200. PubMed ID: 25218345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCDH10 gene inhibits cell proliferation and induces cell apoptosis by inhibiting the PI3K/Akt signaling pathway in hepatocellular carcinoma cells.
    Ye M; Li J; Gong J
    Oncol Rep; 2017 Jun; 37(6):3167-3174. PubMed ID: 28498423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
    Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropivacaine combined with sorafenib attenuates hepatocellular carcinoma cell proliferation and metastasis by inhibiting the miR-224/HOXD10 axis.
    Wang W; Wang T; Lin H; Liu D; Yu P; Zhang J
    Environ Toxicol; 2024 Apr; 39(4):2429-2438. PubMed ID: 38197552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.